Trends in injection risk behaviors in a sample of New York City injection drug users: 1992-1995

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 3, 1999, Pages 283-289

  Beardsley, Mark ^a   Deren, Sherry ^a   Tortu, Stephanie ^a   Goldstein, Marjorie F ^a   Ziek, Kristine ^a   Hamid, Rahul ^a  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

Injection drug users; Injection risk behaviors; Injection risks

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; UNITED STATES;

GOSSYPIUM HIRSUTUM; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032895296     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199903010-00011     Document Type: Article

References (30)

1. Des Jarlais DC, Friedman, SR. HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS 1987;1:67-76.
2. Hahn RA, Onorato IM, Jones S, Dougherty, J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA 1989;261:2677-85.
3. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1987;1:39-44.
4. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989;321:874-9.
5. Koester SK. The risk of HIV transmission from sharing water, drug mixing containers, and cotton filters among intravenous drug users. Int J Drug Policy 1990;1:28-30.
6. Zule WA. Risk and reciprocity:HIV and the injection drug user. J Psychoactive Drugs 1992;24;243-9.
7. Jose B, Friedman SR, Neaigus A, Curtis R, et al. Syringe-mediated drug sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS 1993;7:1653-60.
8. Centers for Disease Control and Prevention. HIV/AIDS Surv Rep 1998;9:10.
9. New York City Department of Health. AIDS surveillance update. June, 1998.
10. Iguchi MY, Bux DA, Lidz V, Kushner H., et al. Interpreting HIV seroprevalence data from a street-based outreach program. J Acquir Immune Defic Syndr 1994;7:491-9.
11. Des Jarlais DC, Friedman SR, Sotheran JL, et al. Continuity and change within an HIV epidemic: injecting drug users in New York City, 1984 through 1992. JAMA 1994;271:121-7.
12. Des Jarlais DC, Perlis T, Friedman SR, et al. Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991-1996. Am J Public Health 1998;88:1801-6.
13. Stephens RC, Feucht TE, Roman SW. Effects of an intervention program on AIDS-related drug and needle behavior among intravenous drug users. Am J Public Health 1991;81:568-71.
14. Colon HM, Robles, RR, Sahai H, Matos T. Changes in HIV risk behaviors among intravenous drug users in San Juan, Puerto Rico. Br J Addiction 1992;87:585-90.
15. McKusker J, Stoddard AM, Zapka JG, et al. AIDS education for drug abusers: evaluation of short-term effectiveness. Am J Public Health 1992;82:533-40.
16. Deren S, Beardsley M, Tortu S, Davis R, Clatts M. Behavior change strategies for women for high risk of HIV. Drugs and Soc 1993;7:119-28.
17. Booth RE, Watters JK. How effective are risk reduction interventions targeting injecting drug users? AIDS 1994;8:1515-24.
18. Kelly JA, Murphy DA, Washington CD, et al. The effects of HIV/ AIDS intervention groups for high-risk women in urban clinics. Am J Public Health 1994;84:1918-22.
19. Deren S, Davis WR, Beardsley M, Tortu S, Clatts M. Outcomes of a risk reduction intervention with high risk populations: the Harlem AIDS project. AIDS Educ Prev 1995;7:379-90.
20. Deren S, Davis WR, Tortu S, Beardsley M, Ahluwalia I, National AIDS Research Consortium. Women at high risk for HIV: pregnancy and risk behaviors. J Drug Issues 1995;25:57-71.
21. Catania JA, Coates TJ, Peterson J, et al. Changes in condom use among Black, Hispanic, and White heterosexuals in San Francisco: the AMEN cohort survey. J Sex Res 1993;30:121-8.
22. Catania JA, Binson D, Dolcini MM, et al. Risk factors for HIV and other sexually transmitted diseases and prevention practices among U.S. heterosexual adults: changes from 1990 to 1992. Am J Public Health 1995;85:1492-9.
23. Choi KH, Catania JA. Changes in multiple sexual partnerships, HIV testing, and condom use among U.S. heterosexuals 18 to 49 years of age, 1990 and 1992. Am J Public Health 1996;86:554-6.
24. McCusker J, Stoddard AM, Koblin BA, et al. Time trends in high-risk injection practices in a multi-site study in Massachusetts: effects of enrollment site and residence. AIDS Educ Prev 1992;4: 108-19.
25. Colon HM, Sahai H, Robles RR, Matos TD. Effects of a community outreach program in HIV risk behaviors among injection drug users in San Juan, Puerto Rico: an analysis of trends. AIDS Educ Prev 1995;7:195-209.
26. Des Jarlais DC, Perlis T, Friedman SR, et al. Risk reduction in a declining HIV epidemic: injecting drug users in New York City, 1990-1997. Manuscript in preparation.
27. Needle R, Fisher DG, Weatherby N, Chitwood, D, et al. The reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav 1995;9:242-50.
28. Weatherby NL, Needle R, Cesari H, et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Eval Prog Planning 1994;17:347-55.
29. Lurie P, ed. The public health impact of needle-exchange programs in the United States and abroad: summary, conclusions, and recommendations. San Francisco: University of California, San Francisco, Institute for Health Policy Studies.
30. Watters J, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 1994;271:115-20.